EBR Systems, Inc. - CDI

EBR Systems, Inc. - CDI is a depositary receipt representing shares in EBR Systems, Inc., a medical device company focused on innovative treatments for cardiac rhythm disorders. The company develops implantable systems for wireless tissue stimulation, with its flagship WiSE cardiac resynchronization therapy system providing leadless pacing to endocardial heart tissue. This technology corrects abnormal heart rhythms without traditional wires or leads, addressing common complications in conventional cardiac pacing for heart failure patients. EBR Systems also advances investigational devices like SOLVE-CRT and supports clinical studies such as the Totally Leadless CRT trial. Operating in the healthcare equipment sector, it serves cardiac specialists and hospitals by enhancing patient outcomes through physiologically effective stimulation. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems, Inc. - CDI plays a key role in advancing wireless cardiac electrophysiology solutions in the medical device market.